This information is intended for healthcare professionals based in Belgium and Luxembourg.

ECLIPSE 6



Dual I-O: Experience in Mesothelioma

Dr Sjaak Burgers, the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital (NKI/AVL), the Netherlands


Dr Burgers discusses a 81 year old male patient diagnosed with mesenchymal mesothelioma. He discusses his approach to managing this patient, including efficacy parameters, as well as management of syndrome of inappropriate antidiuretic hormone and adrenal insufficiency, which was experienced by this patient during treatment.



Interested in the article Dr. Burgers is referring to in this talk? Click here or scan here:

Dual I-O: Experience in NSCLC

Prof Solange Peters, Centre Hospitalier, Universitaire Vaudois, Lausanne, Switzerland


Prof Peters discusses a 50 year old male patient diagnosed with non-squamous, PD-L1 <1% metastatic NSCLC. She discusses her approach to managing this patient, including efficacy parameters, as well as management of rash grade 1–2, which was experienced by this patient during treatment.




Meet-the-Expert:

Interactive Panel Discussion


Topics discussed by Dr Burgers and prof Peters included second-line treatment options in mNSCLC, rechallenge with immunotherapy for patients with mNSCLC and MPM who experience a relapse on immunotherapy, management of patients with brain metastases, treatment discontinuations and immune-mediated adverse events and quality of life.





Back to Overview


© 2023 Bristol-Myers Squibb Belgium SA/NV, with its registered office at Chaussée de La Hulpe 185, 1170 Brussels, and having a place of business at Parc de l’Alliance, Avenue de Finlande 4, 1420 Braine-l’Alleud.

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company. ONC-BE-2300035 – Mar/2023

Legal Notice | Privacy Policy | Contact